Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 5
2018 4
2019 2
2020 7
2021 4
2022 11
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies.
Blanco E, Silva-Pilipich N, Bocanegra A, Chocarro L, Procopio A, Ausín K, Fernandez-Irigoyen J, Fernández L, Razquin N, Igea A, Garnica M, Echaide M, Arasanz H, Vera R, Escors D, Smerdou C, Kochan G. Blanco E, et al. Among authors: arasanz h. Br J Cancer. 2024 Mar;130(5):869-879. doi: 10.1038/s41416-023-02561-y. Epub 2024 Jan 9. Br J Cancer. 2024. PMID: 38195888 Free PMC article.
Immunogenicity of COVID-19 vaccines in lung cancer patients.
Provencio M, Estival A, Franco F, López-Vivanco G, Saigí M, Arasanz H, Diz P, Carcereny E, García J, Aguado C, Mosquera J, Iruarrizaga E, Majem M, Bosch-Barrera J, Mielgo-Rubio X, Guirado M, Juan-Vidal Ó, Blasco A, Lucía Gozálvez C, Del Barrio A, De Portugal T, López-Martín A, Serrano G, Campos B, Rubio J, Catot S, Esteban B, Martí-Ciriquian JL, Del Barco E, Calvo V; Spanish Lung Cancer Group (SLGC/GECP). Provencio M, et al. Among authors: arasanz h. Lung Cancer. 2023 Oct;184:107323. doi: 10.1016/j.lungcan.2023.107323. Epub 2023 Aug 9. Lung Cancer. 2023. PMID: 37639820 Free article.
State of the Art: ctDNA in Upper Gastrointestinal Malignancies.
Labiano I, Huerta AE, Arrazubi V, Hernandez-Garcia I, Mata E, Gomez D, Arasanz H, Vera R, Alsina M. Labiano I, et al. Among authors: arasanz h. Cancers (Basel). 2023 Feb 21;15(5):1379. doi: 10.3390/cancers15051379. Cancers (Basel). 2023. PMID: 36900172 Free PMC article. Review.
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer.
Auclin E, Benitez-Montanez J, Tagliamento M, Parisi F, Gorria T, Garcia-Campelo R, Dempsey N, Pinato DJ, Reyes R, Albarrán-Artahona V, Dall'Olio F, Soldato D, Hendriks L, Nana FA, Tonneau M, Lopez-Castro R, Nadal E, Kazandjian S, Muanza T, Blanc-Durand F, Fabre E, Castro N, Arasanz H, Rochand A, Besse B, Routy B, Mezquita L. Auclin E, et al. Among authors: arasanz h. Lung Cancer. 2023 Apr;178:116-122. doi: 10.1016/j.lungcan.2023.02.002. Epub 2023 Feb 4. Lung Cancer. 2023. PMID: 36812760
Cutting-Edge CAR Engineering: Beyond T Cells.
Chocarro L, Blanco E, Fernández-Rubio L, Arasanz H, Bocanegra A, Echaide M, Garnica M, Ramos P, Piñeiro-Hermida S, Vera R, Kochan G, Escors D. Chocarro L, et al. Among authors: arasanz h. Biomedicines. 2022 Nov 24;10(12):3035. doi: 10.3390/biomedicines10123035. Biomedicines. 2022. PMID: 36551788 Free PMC article. Review.
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.
Escors D, Bocanegra A, Chocarro L, Blanco E, Piñeiro-Hermida S, Garnica M, Fernandez-Rubio L, Vera R, Arasanz H, Kochan G. Escors D, et al. Among authors: arasanz h. Int J Mol Sci. 2022 Oct 31;23(21):13241. doi: 10.3390/ijms232113241. Int J Mol Sci. 2022. PMID: 36362027 Free PMC article. Review.
41 results